10 Key Things You Need to Know About Eylea by Regeneron and Bayer

Eylea is a medication that is commonly used to treat certain eye conditions such as wet age-related macular degeneration (AMD) and diabetic macular edema. It is manufactured by Regeneron Pharmaceuticals in collaboration with Bayer. Here are 10 key things you need to know about Eylea:

  1. How Eylea Works: Eylea works by blocking a protein called VEGF (vascular endothelial growth factor) which is responsible for the growth of abnormal blood vessels in the eye.
  2. Administration: Eylea is administered via injection directly into the eye by a healthcare professional.
  3. Frequency of Injections: The frequency of Eylea injections may vary depending on the specific eye condition being treated. Your doctor will determine the appropriate dosing schedule for you.
  4. Possible Side Effects: Some common side effects of Eylea include eye pain, redness, and increased intraocular pressure. Serious side effects such as retinal detachment and endophthalmitis are rare but can occur.
  5. Monitoring: It is important to have regular eye exams while receiving Eylea treatment to monitor for any changes in your eye condition.
  6. Cost: Eylea can be expensive, but there are financial assistance programs available for eligible patients to help with the cost of treatment.
  7. Effectiveness: Clinical studies have shown that Eylea is highly effective in improving vision and slowing the progression of certain eye conditions.
  8. Precautions: Before starting Eylea treatment, inform your doctor if you have any allergies, infections, or other medical conditions.
  9. Alternative Treatments: In addition to Eylea, there are other medications available to treat eye conditions such as Lucentis and Avastin. Your doctor will help determine the best treatment option for you.
  10. Consultation: If you are considering Eylea treatment, schedule a consultation with an eye specialist to discuss the potential benefits and risks of the medication.